Persistent Activation of CD8+ T-cells Characterizes Prediabetic Twins

OBJECTIVE Elevated circulating levels of activated CD3+ T-cells are characteristic of type I diabetes at diagnosis, and activated CD8+ (cytotoxic/suppressor) T-cells predominate in the islet infiltrate. The aim of this study was to examine the peripheral blood of prediabetic and nondiabetic identical twins of patients with type I diabetes for the presence of activated CD8+ T-cells and by comparing these groups, analyze the relationship of such cells to the development of the disease. RESEARCH DESIGN AND METHODS In a 10-year prospective study, blood T-cell subsets (CD3+ total T-cells, CD4+ helper/inducer, and CD8+ cytotoxic/suppressor) were analyzed for evidence of activation (cell surface expression of HLA-DR, CD25) in 18 identical twins of patients with type I diabetes, 8 of whom became diabetic (prediabetic twins), while 10 remained nondiabetic after at least 8 years of follow-up and are now at low risk for type I diabetes. Fifteen healthy individuals were studied as control subjects. RESULTS At the beginning and during the study, percentage levels of activated CD3+ HLA-DR+ T-cells were significantly elevated in prediabetic and low-risk twins compared with control subjects (P < 0.005) but remained high only in prediabetic twins (P < 0.005). Both prediabetic and low-risk twins had elevated levels of HLA-DR+ CD4+ T helper cells compared with control subjects throughout the study (P < 0.001), and these remained high in both (P < 0.001 and P < 0.05, respectively). Only prediabetic twins had elevated levels of HLA-DR+ CD8+ T-cells during the study. These were significantly higher than in control subjects (P < 0.005) and low-risk twins (P < 0.05) and remained persistently elevated to diagnosis (P < 0.001). Abnormally elevated levels of HLA-DR+ CD8+ T-cells in twins indicate a 50% risk of progression to type I diabetes by life-table analysis (P = 0.01), with a positive predictive value of 100%, sensitivity of 50%, and specificity of 100%. Elevated CD25+ T-cell levels in prediabetic and low-risk twins were less marked and less able to discriminate between the twin groups. CONCLUSIONS These results demonstrate that prediabetes is characterized by persistent elevation of HLA-DR+ CD8+ T-cells with the same cytotoxic phenotype as cells predominating in the islet at diagnosis, suggesting that the circulating cells may have a role in the pathogenesis of islet damage.

[1]  M. Hussain,et al.  Increased Expression of T-Cell Markers of Immunological Memory Associated with Protection from Type I Diabetes: A study of Identical Twins , 1994, Diabetes.

[2]  A. Beavis,et al.  Tracking of murine spleen cells in vivo: detection of PKH26-labeled cells in the pancreas of non-obese diabetic (NOD) mice. , 1994, Journal of immunological methods.

[3]  L. Harrison,et al.  Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes , 1993, The Lancet.

[4]  O. Simell,et al.  Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[5]  R. Leslie,et al.  Antibodies to GAD and Tryptic Fragments of Islet 64K Antigen as Distinct Markers for Development of IDDM: Studies With Identical Twins , 1992, Diabetes.

[6]  M. Erlander,et al.  Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes , 1992, The Lancet.

[7]  R. Leslie,et al.  Studies of diabetic twins. , 1991, Diabetes/metabolism reviews.

[8]  S. Romagnani Human TH1 and TH2 subsets: doubt no more. , 1991, Immunology today.

[9]  S. Arden,et al.  T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes , 1991, The Lancet.

[10]  Bart O. Roep,et al.  T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins , 1990, Nature.

[11]  D. Vergani,et al.  Effect of Initiation of Insulin Therapy on T‐lymphocyte Activation in Type 1 Diabetes , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[12]  E. Bonifacio,et al.  Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes , 1990, The Lancet.

[13]  M. Feldmann,et al.  DO CD4-POSITIVE CYTOTOXIC T CELLS DAMAGE ISLET β CELLS IN TYPE 1 DIABETES? , 1988, The Lancet.

[14]  M. Feldmann,et al.  The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+. , 1988, Clinical and experimental immunology.

[15]  D. R. Gamble,et al.  In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. , 1985, The New England journal of medicine.

[16]  A. Michael,et al.  Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[17]  Hoskins,et al.  PATHOGENESIS OF INSULIN-DEPENDENT DIABETES: A ROLE FOR ACTIVATED T LYMPHOCYTES , 1984, The Lancet.

[18]  P. Pozzilli,et al.  Monoclonal Antibodies Defined Abnormalities of T-Lymphocytes in Type I (Insulin-dependent) Diabetes , 1983, Diabetes.

[19]  B. Haynes,et al.  Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. , 1982, The New England journal of medicine.

[20]  Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.

[21]  K. C. Tan,et al.  T cell clones generated from patients with type 1 diabetes using interleukin-2 proliferate to human islet antigens. , 1994, Autoimmunity.

[22]  M. Feldman,et al.  Human islet cell induced T cell lines and clones from diabetic children. , 1991, Autoimmunity.

[23]  G. Eisenbarth,et al.  Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. , 1990, Annual review of immunology.